Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes

Diabetes Technology and Therapeutics

Volumn 11, Issue 3, 2009, Pages 131-137

  Babar, Ghufran S ^a   Ali, Omar ^a   Parton, Elaine A ^a   Hoffmann, Raymond G ^a   Alemzadeh, Ramin ^a,b  

^a Medical College of Wisconsin ^*  (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN LISPRO;

ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; DRUG INFUSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LIPOHYPERTROPHY; MALE; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; RETROSPECTIVE STUDY; SCREENING; SELF MONITORING; TEAMWORK;

ADOLESCENT; AGE OF ONSET; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSION PUMPS, IMPLANTABLE; INSULIN INFUSION SYSTEMS; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PUBERTY;

EID: 62249160710     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0042     Document Type: Article

References (47)

1. Tamborlane WV, Sherwin RS, Genel M, Felig P: Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;300:573-578.
2. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994;125:177-188.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
4. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001;139:804-812.
5. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP: Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001;107:351-356.
6. Sulli N, Shashaj B: Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003;16:393-399.
7. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003;112:559-564.
8. Weinzimer SA, Sikes KA, Steffen AT, Tamborlane WV: Insulin pump treatment of childhood type 1 diabetes. Pediatr Clin North Am 2005;52:1677-1688.
9. Schoenle EJ, Lang-Muritano M, Gschwend S, Laimbacher J, Mullis PE, Torresani T, Biason-Lauber A, Molinari L: Epidemiolgoy of type 1 diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade. Diabetologia 2001;44:286-289.
10. Gardner SG, Bingley PJ, Satwell PA, Weeks S, Gale AM; Bart's-Oxford Study Group: Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. BMJ 1997;315:713-717.
11. Charkaluk M-L, Czernichow P, Levy-Marchal C: Incidence data of childhood-onset type 1 diabetes in France during 1988-1997: the case for a shift toward younger age at onset. Pediatr Res 2002;52:859-862.
12. Dahlquist G, Mustonen L; Swedish Diabetes Study Group: Analysis of 20 years of prospective registration of childhood onset diabetes - time trends and birth cohort effects. Acta Pediatr 2000;89:1231-1237.
13. DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA: A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145:380-384.
14. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N: A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005;28:1277-1281.
15. Juliusson PB, Graue M, Wentzel-Larsen T, Sovik O: The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes. Acta Paediatr 2006;95:1481-1487.
16. Slijper FM, De Beaufort CE, Bruining GJ, De Visser JJ, Aarsen RS, Kicken DA, Van Strik R: Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy. Diabete Metab 1990;16:273-277.
17. O'Neil KJ, Jonnalagadda SS, Hopkins BL, Kicklighter JR: Quality of life and diabetes knowledge of young persons with type 1 diabetes: influence of treatment modalities and demographics. J Am Diet Asoc 2005;105:85-91.
18. Watkins PJ: Pros and cons of continous subcutaneous insulin infusion. Br Med J (Clin Res Ed) 1985;209:655-656.
19. Guinn TS, Bailey GJ, Mecklenburg RS: Factors related to discontinuation of subcutaneous insulin-infusion therapy. Diabetes Care 1988;11:46-51.
20. Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P: Insulin pump therapy in pediaric patients: now and into the year 2000. Diabetes Metab Res Rev 1999;15:338-352.
21. Lenhard MJ, Reeves GD: Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001;161:2293-2300.
22. Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP: Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 2007;9:421-428.
23. Conrad Sc, McGrath MT, Gitelman SE: Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002;140:235-240.
24. Willi SM, Planton J, Egede L, Schwarz S: Benefits of continuous subcutaneous insulin infsion in children with type 1 diabetes. J Pediatr 2003;143:796-801.
25. Alemzadeh R, Berhe T, Wyatt DT: Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 2005;115:1320-1324.
26. Berhe T, Postellon D, Wilson B, Stone R: Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Pediatrics 2006;117:2132-2137.
27. DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA: A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145:380-384.
28. de Beaufort CE, Houtzagers CM, Bruining GJ, Aarsen RS, den Boer NC, Grose WF, van Strik R, de Visser JJ: Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989;6:766-771.
29. Sulli N, Shashaj B: Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Diabet Med 2006;23:900-906.
30. Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LM: Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 2006;29:2355-2360.
31. Knight G, Boulton AJ, Ward JD: Experience of continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers. Diabet Med 1986;3:82-84.
32. Schmidt K, Boehm BO, Schifferdecker E, Usadel KH: Long-term adherence to intensified conventional insulin therapy. Exp Clin Endocrinol Diabetes 1995;103:256-259.
33. Alemzadeh R, Loppnow C, Parton E, Kirby M: Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 2003;5:167-173.
34. Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT: Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004;114:e91-e95.
35. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26:1079-1087.
36. Nabhan ZM, Rardin L, Meier J, Eugster EA, Dimeglio LA: Predictors of glycemic control on insulin pump therapy in children and adolescents with type I diabetes. Diabetes Res Clin Pract 2006;74:217-221.
37. Plotnick LP, Clark LM, Brancati FL, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142-1146.
38. Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ: Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004;113:e221-e224.
39. Danne T, Battelino T, Kordonouri O, Hanas R, Klinkert C, Ludvigsson J, Barrio R, Aebi C, Gschwend S, Mullis PE, Schumacher U, Zumsteg U, Morandi A, Rabbone I, Cherubini V, Toni S, de Beaufort C, Hindmarsh P, Sumner A, van Waarde WM, van den Berg N, Phillip M: A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes 2005;6:193-198.
40. Palmer DL, Berg CA, Wiebe DJ, Beveridge RM, Korbel CD, Upchurch R, Swinyard MT, Lindsay R, Donaldson DL: The role of autonomy and pubertal status in understanding age differences in maternal involvement in diabetes responsibility across adolescence. J Pediatr Psychol 2004; 29:35-46.
41. Hauner H, Stockamp B, Haastert B: Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes 1996;104:106-110.
42. Richardson T, Kerr D: Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol 2003;4:661-667.
43. Schifferdecker E, Schmidt K, Boehm BO, Schatz H. Long-term compliance of intensified insulin therapy. Diabetes Res Clin Pract 1994;23:17-23.
44. Lloyd CE, Dyer PH, Barnett AH: Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med 2000;17:198-202.
45. Chase HP, Horner B, McFann K, Yetzer H, Gaston J, Banion C, Fiallo-Scharer R, Slover R, Klingensmith G: The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care 2006;29:1012-1015.
46. Gross TM, Kayne D, King A, Rother C, Juth S: A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther 2003;5:365-369.
47. Lee SW, Cao M, Sajid S, Hayes M, Choi L, Rother C, de Le¢n R: The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes. Diabetes Nutr Metab 2004;17:211-216.